Table 2.
Goodness-of-Fit Statistics for the PFS and OS by treatment groups.
| Treatment | Curve (Weibull) | AIC | BIC | Mean (month) | Median (month) |
|---|---|---|---|---|---|
| Dacomitinib | PFS (IRC) | 545.20 | 552.04 | 18.67 | 14.74 |
| PFS (INV) | 530.36 | 537.21 | 19.06 | 15.70 | |
| OS | 465.03 | 471.88 | 38.92 | 33.36 | |
| Gefitinib | PFS (IRC) | 514.46 | 521.29 | 11.80 | 10.25 |
| PFS (INV) | 513.42 | 520.25 | 13.25 | 11.60 | |
| OS | 461.29 | 468.12 | 32.01 | 28.55 |
AIC, Akaike information criterion; BIC, Bayesian information criterion; IRC, independent review committee; INV, investigator; OS, overall survival.